Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry (Q48120604)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 December 2013

Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry

Language	Label	Description	Also known as
English	Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry	scientific article published on 8 December 2013	Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

quality of life

1 reference

based on heuristic

inferred from title

author name string

M W M van der Poel

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

S Oerlemans

2

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

H C Schouten

3

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

F Mols

4

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

J F M Pruijt

5

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

H Maas

6

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

L V van de Poll-Franse

7

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

publication date

8 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

93

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

5

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

811-819

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Health status and quality of life among non-Hodgkin lymphoma survivors

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

The impact of cancer and quality of life for post-treatment non-Hodgkin lymphoma survivors

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Post-traumatic stress disorder and quality of life in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma in Israel.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Young adult cancer survivors' psychosocial well-being: a cross-sectional study assessing quality of life, unmet needs, and health behaviors

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Quality of life, lifestyle behavior and employment experience: a comparison between young and midlife survivors of gynecology early stage cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

The impact of cancer and quality of life for long-term survivors

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Socio-economic implications of cancer survivorship: results from the PROFILES registry

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: a population-based study.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy era.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Impact of rituximab on treatment outcomes of patients with diffuse large b-cell lymphoma: a population-based analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1980-1

21 January 2018

Identifiers

10.1007/S00277-013-1980-1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24318593

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48120604&oldid=2186179279"